Agilon Health, Inc. (AGL)
$
0.96
-0.01 (-1.04%)
Key metrics
Financial statements
Free cash flow per share
-0.1705
Market cap
397.8 Million
Price to sales ratio
0.0674
Debt to equity
0.1012
Current ratio
1.1630
Income quality
0.1796
Average inventory
0
ROE
-0.6459
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilon Health, Inc. specializes in providing healthcare services for seniors in communities across the United States through primary care physicians. As of December 31, 2021, the company served approximately 238,000 senior members, which included 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. The company recorded an operating income of -$292,130,000.00 reflecting its earnings from core operations. Additionally, the total costs and expenses for the company are $6,352,660,000.00 reflecting its overall spending. The net total of other income and expenses is $43,304,000.00 reflecting non-core financial activities. The EBITDA is -$218,186,000.00 a key indicator of the company's operational profitability. Furthermore, the weighted average number of diluted shares outstanding is $410,966,000.00 reflecting potential dilution effects. Agilon Health, Inc., which was formerly known as Agilon Health Topco, Inc. until March 2021, was founded in 2016 and is based in Austin, Texas. In the financial market, the stock is affordable at $1.16 making it suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of $11,376,925.00 indicating strong liquidity. With a market capitalization of $397,804,781.00 the company is classified as a small-cap player, which can provide unique opportunities for growth. It is a key player in the $Medical - Care Facilities industry, contributing significantly to the overall market landscape. Moreover, it belongs to the $Healthcare sector, driving innovation and growth within its market niche. Together, these attributes highlight the company's standing and potential for investors seeking involvement in the healthcare sector focused on senior care.
Investing in Agilon Health, Inc. (AGL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Agilon Health, Inc. stock to fluctuate between $0.71 (low) and $6.08 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-10-17, Agilon Health, Inc.'s market cap is $397,804,781, based on 414,423,149 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Agilon Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
Agilon Health, Inc. pays dividends. The current dividend yield is 5.81%, with a payout of $0.45 per share.
To buy Agilon Health, Inc. (AGL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AGL. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Revenue: $6,060,530,000 | EPS: -$0.63 | Growth: -1.56%.
Visit https://agilonhealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $38.47 (2021-09-02) | All-time low: $0.71 (2025-08-05).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
businesswire.com
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. So What: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr.
globenewswire.com
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
globenewswire.com
NEW YORK, Oct. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
prnewswire.com
NEW YORK , Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
businesswire.com
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. So What: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr.
zacks.com
AGL, PLAY and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Agilon and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
globenewswire.com
NEW YORK and NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL).
globenewswire.com
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL).
See all news